Notification Obligation Regarding Holders of Significant Interest in SHL Telemedicine Ltd.

Tel Aviv/Zurich, 24 April 2014 – Under the amended Stock Exchange Act (Börsengesetz – BEHG) and the amended Stock Exchange Ordinance (Börsenverordnung – BEHV), disclosure requirements for significant shareholders pursuant…

Continue ReadingNotification Obligation Regarding Holders of Significant Interest in SHL Telemedicine Ltd.
  • Post category:
  • Post comments:0 Comments

SHL Telemedicine signs agreement in India with Narayana Health Hospitals, one of the leading hospital chains in India.

Tel Aviv/Zurich, 19 March 2014 - SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN), a leading provider and developer of advanced personal telemedicine solutions, is pleased to announce an agreement with…

Continue ReadingSHL Telemedicine signs agreement in India with Narayana Health Hospitals, one of the leading hospital chains in India.
  • Post category:
  • Post comments:0 Comments

SHL announces preliminary results for the year ended December 31, 2013 Revenue growth with operating and net profit

Tel Aviv/Zurich, 5 February 2014 - SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN), a leading provider and developer of advanced personal telemedicine solutions, is pleased to announce its preliminary financial…

Continue ReadingSHL announces preliminary results for the year ended December 31, 2013 Revenue growth with operating and net profit
  • Post category:
  • Post comments:0 Comments

SHL closes acquisition of almeda and will recognize in 2013 an operating profit of 5-7 M$ from the transaction. Will contribute yearly revenues of 7 to 10 M$

Tel Aviv/Zurich, 2 January, 2013 - SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN), a leading provider and developer of advanced personal telemedicine solutions, announced today that it has closed the…

Continue ReadingSHL closes acquisition of almeda and will recognize in 2013 an operating profit of 5-7 M$ from the transaction. Will contribute yearly revenues of 7 to 10 M$
  • Post category:
  • Post comments:0 Comments